World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
10525
World Ranking
3958
National Ranking
2

Research.com Recognitions

  • 2004 - Fellow, The World Academy of Sciences

Overview

Peter Mugyenyi is affiliated with the Uganda National Academy of Sciences in Uganda and conducts research primarily in the fields of Medicine and Immunology and Microbiology. Their work spans several subfields, including Infectious Diseases, Virology, and Epidemiology, with particular emphasis on HIV-related studies and associated complications.

The research topics covered by Peter Mugyenyi include:

  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS Research and Interventions
  • Cytomegalovirus and herpesvirus research
  • HIV/AIDS drug development and treatment
  • Tuberculosis Research and Epidemiology

Among the recent papers associated with Peter Mugyenyi are:

  • Translocated microbiome composition determines immunological outcome in treated HIV infection, 2021, published in Cell
  • Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial, 2022, published in Journal of the International AIDS Society
  • Effectiveness of a mobile antiretroviral pharmacy and HIV care intervention on the continuum of HIV care in rural Uganda, 2020, published in AIDS Care
  • Scale-up of HIV Treatment Through PEPFAR: A Historic Public Health Achievement, 2020, published in UNC Libraries
  • Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial, 2020, published in UNC Libraries

Peter Mugyenyi frequently collaborates with several coauthors, including:

  • Evelyn Hogg
  • Vidya Mave
  • Lerato Mohapi
  • Krystelle Nganou-Makamdop
  • Aarthi Talla

The scientist's work is often published in venues such as:

  • UNC Libraries
  • Cell
  • Journal of the International AIDS Society
  • AIDS Care

Peter Mugyenyi was awarded the title of Fellow of The World Academy of Sciences in 2004. This recognition points to the standing held within the scientific community in areas related to infectious diseases and treatment research.

Best Publications

  • Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

    Diane V. Havlir;Michelle A. Kendall;Prudence Ive;Johnstone Kumwenda

  • A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus

    Whalen Cc;Johnson Jl;Okwera A;Hom Dl

  • Depletion of Regulatory T Cells in HIV Infection Is Associated with Immune Activation

    Mark P. Eggena;Banson Barugahare;Norman Jones;Martin Okello

  • Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

    Paul J Weidle;Samuel Malamba;Raymond Mwebaze;Catherine Sozi

  • Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

    Jessica H. Oyugi;Jayne Byakika-Tusiime;Edwin D. Charlebois;Cissy Kityo

  • Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

    Jessica H Oyugi;Jayne Byakika-Tusiime;Kathleen Ragland;Oliver Laeyendecker

  • Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients

    Z. Toossi;Z. Toossi;H. Mayanja-Kizza;C. S. Hirsch;K. L. Edmonds

  • Adherence to HIV antiretroviral therapy in HIV+ ugandan patients purchasing therapy

    Jayne Byakika-Tusiime;J. H. Oyugi;W. A. Tumwikirize;E. T. Katabira

  • Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

    Nicholas I. Paton;Cissy Kityo;Anne Hoppe;Andrew Reid

  • Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa.

    J Hakim;V Musiime;AJ Szubert;J Mallewa

  • Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults.

    John L. Johnson;Alphonse Okwera;David L. Hom;Harriet Mayanja

  • Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections.

    George P Schmid;Anne Buvé;Peter Mugyenyi;Geoff P Garnett

  • Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV-Infected Adults in Africa Initiating Antiretroviral Therapy

    Andrew Reid;Wolfgang Stöhr;A. Sarah Walker;Ian G. Williams

  • Apoptosis and T Cell Hyporesponsiveness in Pulmonary Tuberculosis

    Christina S. Hirsch;Zahra Toossi;Guido Vanham;John L. Johnson

  • Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

    AS Walker;D Ford;CF Gilks;P Munderi

  • Scale-up of HIV treatment through PEPFAR: a historic public health achievement.

    Wafaa M. El-Sadr;Charles B. Holmes;Peter Mugyenyi;Harsha Thirumurthy

  • Augmentation of Apoptosis and Interferon-γ Production at Sites of Active Mycobacterium tuberculosis Infection in Human Tuberculosis

    C. S. Hirsch;Z. Toossi;J. L. Johnson;H. Luzze

  • Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.

    Scott Robert Penzak;G. Kabuye;P. Mugyenyi;F. Mbamanya

  • Antiretroviral therapy and sexual behavior: A comparative study between antiretroviral-naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda

    Moses Bateganya;Grant Colfax;Leigh Anne Shafer;Cissy Kityo

  • Hematological reference ranges among healthy Ugandans.

    S B Tugume;E M Piwowar;T Lutalo;P N Mugyenyi

  • Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection : Potential mechanisms of viral activation

    Zahra Toossi;John L. Johnson;Richard A. Kanost;Mianda Wu

  • A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis: A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

    S. Schwander;S. Rüsch-Gerdes;A. Mateega;T. Lutalo

  • T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB).

    T. Hertoghe;A. Wajja;L. Ntambi;A. Okwera

  • T Cell Activation in HIV-Seropositive Ugandans: Differential Associations with Viral Load, CD4+ T Cell Depletion, and Coinfection

    Mark P. Eggena;Banson Barugahare;Martin Okello;Steven Mutyala

  • Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

    Francis Ssali;Wolfgang Stöhr;Paula Munderi;Andrew Reid

  • Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.

    Álvaro H. Borges;Jacqueline Neuhaus;Abdel G. Babiker;Keith Henry

Frequent Co-Authors

Cissy Kityo
Cissy Kityo Joint Clinical Research Centre
Robert A. Salata
Robert A. Salata Case Western Reserve University
Diana M. Gibb
Diana M. Gibb University College London
Eric J. Arts
Eric J. Arts University of Western Ontario
Tobias F. Rinke de Wit
Tobias F. Rinke de Wit University of Amsterdam
Charles F. Gilks
Charles F. Gilks University of Queensland
A. Sarah Walker
A. Sarah Walker University of Oxford
Glenn Wagner
Glenn Wagner RAND Corporation
Nicholas I. Paton
Nicholas I. Paton National University of Singapore
Heiner Grosskurth
Heiner Grosskurth University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career opportunities in healthcare, research, and public health. To complement a microbiology background, students can explore specialized online programs that enhance their expertise and career prospects.

For those interested in managing health data, the best online health information management degree cahiim accredited programs offer a strong foundation in health informatics and data analysis, crucial for modern healthcare systems.

Alternatively, accelerated online options like the accelerated medical billing and coding certificate online can quickly prepare graduates for essential administrative roles in medical facilities.

For those seeking comprehensive qualifications, exploring what medical degrees can i get online is advisable. These degrees often provide flexible pathways toward careers in healthcare delivery.

Public health professionals with a microbiology focus may also consider easy mph online programs. These programs support career growth in epidemiology, health policy, and disease prevention, often available through fully online formats.

Choosing the right online program can significantly impact career development, making it important to assess accreditation, curriculum, and flexibility when advancing in the field of microbiology and related health sciences.

Best Scientists Citing Peter Mugyenyi

Trending Scientists

Recently Published Articles